- S&P 500 Futures struggle to extend the two-day rise amid mixed clues.
- Trade war fears join a light calendar to challenge the market’s previous optimism.
- Coronavirus case numbers jump in Texas but vaccine hopes dim the pandemic woes.
- Fed is widely expected to keep the monetary policy unchanged, quarterly economic forecast will be the key.
S&P 500 Futures tread water around 3,390, down 0.10% intraday, during early Wednesday. In doing so, the risk barometer snaps the last two days’ run-up ahead of the US Federal Reserve (Fed) announcements.
Other than the traders’ generally followed pre-event cautious sentiment, a light calendar and mostly dead news feeds also add to the market’s lack of activity.
Even so, recent trade jitters between the US and Canada, surrounding the American aluminum tariffs, join the coronavirus (COVID-19) news to offer intermediate moves.
Following its open threat to any further aluminum tariffs from the US, Ottawa extended the border restrictions with America by a month to October 21.
Also on the trade side could be the World Trade Organization’s (WTO) verdict terming the US sanctions on China as against international law.
Elsewhere, Texas registered the biggest jump in daily cases with 4,816 addition for Tuesday. Though hopes of finding the cure to the pandemic, backed by the latest research at the University of Pittsburgh School Of Medicine, conquer the virus woes.
Looking at the calendar, New Zealand’s Current Account data for the second quarter flashed upbeat signs and so does Japan’s August month Merchandise Trade Balance Total. Further, Australia’s Westpac Leading Index grew past-0.06% prior readings to 0.48% in the previous month.
Moving on, traders will pay a little heed to the second-tier economics, if any, ahead of the US Fed’s monetary policy announcements. Though, the UK Consumer Price Index and Retail Sales from American may offer intermediate moves. It should, additionally, be noted that the risk catalysts may gain upside momentum should the Fed chooses to sound optimistic.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.